4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-16-000042
former Chairman sold 909,878 shares at an average $0.33 ($301,266)
- former Chairman acquired 124,646 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
TREPPEL JERRY · former Chairman
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-01-29 | Sale : show line 1 in the form | −115,000 | $0.35 | $40,250 | 9,081,769 | D |
| 2016-02-01 | Sale : show line 2 in the form | −312,300 | $0.34 | $106,182 | 8,769,469 | D |
| 2016-02-02 | Sale : show line 3 in the form | −13,000 | $0.33 | $4,290 | 8,756,469 | D |
| 2016-02-03 | Sale : show line 4 in the form | −45,518 | $0.33 | $15,021 | 8,710,951 | D |
| 2016-02-04 | Sale : show line 5 in the form | −349,660 | $0.32 | $111,891 | 8,361,291 | D |
| 2016-02-05 | Sale : show line 6 in the form | −24,400 | $0.33 | $8,052 | 8,336,891 | D |
| 2016-02-16 | Grant or award : show line 7 in the form | +124,646 | $0.25 | $30,900 | 8,461,537 | D |
| 2016-02-17 | Sale : show line 8 in the form | −50,000 | $0.31 | $15,580 | 8,411,537 | D |
| Open-market sales · 909,878 sh · avg $0.33 · $301,266 | ||||||
Loading xslF345X03/primary_doc.xml…